Bifonazole
CAS 60628-96-8
Bifonazole (CAS 60628-96-8) is a Phase 3 pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 14869.33768115942 nM | 69 | - |
| - | MIC | 48.54730158730159 10'-2 umol/ml | 63 | - |
| - | Potency | 20304.14027777778 nM | 52 | - |
| - | MIC | 204931.31707317074 nM | 41 | - |
| - | IC50 | 16157.287826086957 nM | 22 | - |
| - | MIC | 71.49842105263158 ug.mL-1 | 19 | - |
| - | MIC | 50 10'-2mmol/ml | 8 | - |
| - | MIC | 54.28333333333333 10'-2umol | 6 | - |
| - | EC50 | 18900 nM | 2 | - |
| - | Ki | 56.5 nM | 1 | - |
| Cytochrome P450 3A4 Enzyme |
IC50 | 6.1 | - | Homo sapiens |
| Steroid 17-alpha-hydroxylase/17,20 lyase Enzyme |
Ki | 7.25 | - | Homo sapiens |
| Lanosterol 14-alpha demethylase Enzyme |
IC50 | 6.47 | - | Homo sapiens |
| Indoleamine 2,3-dioxygenase 1 Enzyme |
IC50 | 4.64 | - | Homo sapiens |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Bifonazole used for in pharmaceutical contexts?
Bifonazole (CAS 60628-96-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Bifonazole?
No adverse-event association or SIDER side-effect rows are rendered for Bifonazole in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Bifonazole also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Bifonazole with EU status "permitted".
What clinical phase is Bifonazole in?
Bifonazole is rendered with ChEMBL max phase 3.
What bioactivity targets are documented for Bifonazole?
Bifonazole has 14 bioactivity rows in this page query. Rendered target entries include Cytochrome P450 3A4, Steroid 17-alpha-hydroxylase/17,20 lyase, Lanosterol 14-alpha demethylase, Indoleamine 2,3-dioxygenase 1.